Zogenix, Inc. (NASDAQ: ZGNX) reported Q4 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $9.9 million versus the consensus estimate of $8.68 million. Zogenix, Inc. (NASDAQ:ZGNX) stock opened at $4.03 in last session, and closed at $4.54, while the day range of Zogenix, Inc. (NASDAQ:ZGNX) stock is $4.03 – $4.68. The stock showed a positive weekly performance of 0.22%.
Germany has granted Northwest Bio therapeutics Inc. (NASDAQ:NWBO) special permission to sell its experimental brain cancer drug in the country, the company said, and its stock jumped as much as 36 percent. Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) stock opened at $8.29 in last session, and closed at $9.18 by gaining 16.93%. The 52 week range of $3.10 – $10.64. Company’s market capitalization is $323.82 million.
GW Pharmaceuticals PLC – ADR (NASDAQ:GWPH) was up and running in Wednesday trading session moving up by roughly 8% at the back of 724, 311 shares exchanging hands. GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) stock increased 6.63% and finished the last session at $$82.40. The EPS of the stock remained -1.15. Company’s market capitalization is $1.22 billion.
Marina Biotech, Inc. (OTCMKTS:MRNA), a leading nucleic acid-based drug discovery and development company focused on rare diseases, announced that it plans to broadly apply its RNAi, RNAi, antisense and microRNA therapeutics platform to develop drugs for rare diseases. Marina Biotech, Inc. (OTCMKTS:MRNA) stock opened the session at $1.25, and closed the session at $1.40. The 52 week range of the Marina Biotech, Inc. (OTCMKTS:MRNA) stock remained $0.18 – $1.81 and the day range was $1.22 – $1.50.